Bruzzone, M <br/><br/>
Intraperitoneal carboplatin with or without interferon-alpha in advanced ovarian cancer patients with minimal residual disease at second look: a prospective randomized trial of 111 patients. G.O.N.O. Gruppo Oncologic Nord Ovest.  [electronic resource] 

 -  Gynecologic oncology  Jun 1997 
 - 499-505 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0090-8258 
<br/><br/><label>Standard No.: </label>10.1006/gyno.1997.4689  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--administration & dosage<br/>Carboplatin--administration & dosage<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Injections, Intraperitoneal<br/>Interferon-alpha--administration & dosage<br/>Laparotomy<br/>Middle Aged<br/>Neoplasm Staging<br/>Neoplasm, Residual<br/>Ovarian Neoplasms--drug therapy<br/>Prospective Studies<br/>Reoperation